MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
199.72%
Quick Ratio
197.71%
Cash Ratio
172.62%
Debt to Asset Ratio
172.34%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Machinery and equipment, net, an...
    • Right-of-use operating and finan...
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Common stock, no par value, 230,...
    • Contingent consideration liabili...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
17,756
28,201
11,583
18,692
Accounts receivable, net of allowance for credit losses of 2 and 11, respectively
192
157
1,128
258
Inventories
207
382
446
471
Deferred financing costs
-
-
0
-
Restricted cash, current
729
729
729
729
Prepaid expenses and other current assets
1,659
1,048
1,420
1,239
Total current assets
20,543
30,517
15,306
21,389
Right-of-use and financing lease assets, net
-
-
-
2,340
Right-of-use operating and financing lease assets, net
2,097
2,459
2,815
-
Machinery and equipment, net, and construction in progress
6,004
6,452
6,435
4,147
Intangible assets, net
-
-
0
14,600
Restricted cash, noncurrent
243
425
607
789
Other noncurrent assets
556
574
593
672
Total assets
29,443
40,427
25,756
43,937
Accounts payable
1,871
1,615
2,544
1,056
Due to related party (note 9)
1,979
2,736
2,780
-
Accrued compensation
1,904
3,333
2,461
2,228
Accrued royalties
1,116
1,116
1,116
1,120
Accrued expenses and other current liabilities
1,000
1,284
939
602
Right-of-use and financing lease liabilities, current
-
-
-
1,598
Operating and financing lease liabilities, current
1,710
1,762
1,807
-
Contingent consideration liabilities, current
706
159
428
1,056
Total current liabilities
10,286
12,005
12,075
7,660
Right-of-use and financing lease liabilities, noncurrent
-
-
-
1,529
Operating and financing lease liabilities, noncurrent
915
1,307
1,690
-
Contingent consideration liabilities, noncurrent
39,541
37,806
43,455
43,944
Total liabilities
50,742
51,118
57,220
53,133
Preferred stock, no par value, 5,000 shares authorized no shares issued and outstanding
0
0
0
-
Common stock, no par value, 230,000 shares authorized 32,623 and 28,683 shares issued and outstanding at june 30, 2026 and december 31, 2025, respectively
394,945
394,289
369,211
368,524
Accumulated other comprehensive income
67
71
86
86
Accumulated deficit
-416,311
-405,051
-400,761
-377,806
Total shareholders' deficit
-21,299
-10,691
-31,464
-9,196
Total liabilities and shareholders' deficit
29,443
40,427
25,756
43,937
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$17,756K (-26.89%↓ Y/Y)Prepaid expenses andother current assets$1,659K (22.89%↑ Y/Y)Restricted cash, current$729K Inventories$207K (-70.13%↓ Y/Y)Accounts receivable, netof allowance for...$192K (-62.50%↓ Y/Y)Total current assets$20,543K (-23.47%↓ Y/Y)Machinery and equipment,net, and...$6,004K (44.71%↑ Y/Y)Right-of-use operating andfinancing lease assets,...$2,097K Other noncurrentassets$556K (-20.80%↓ Y/Y)Restricted cash,noncurrent$243K (-85.71%↓ Y/Y)Total assets$29,443K (-41.72%↓ Y/Y)Accumulated deficit-$416,311K (-13.45%↓ Y/Y)Total liabilities andshareholders' deficit$29,443K (-41.72%↓ Y/Y)Total shareholders'deficit-$21,299K (-2039.80%↓ Y/Y)Common stock, no parvalue, 230,000 shares...$394,945K (7.33%↑ Y/Y)Accumulated othercomprehensive income$67K (-21.18%↓ Y/Y)Total liabilities$50,742K (2.68%↑ Y/Y)Contingent considerationliabilities, noncurrent$39,541K (-3.40%↓ Y/Y)Total currentliabilities$10,286K (54.63%↑ Y/Y)Operating and financinglease liabilities,...$915K Due to related party(note 9)$1,979K Accrued compensation$1,904K (30.50%↑ Y/Y)Accounts payable$1,871K (46.52%↑ Y/Y)Operating and financinglease liabilities,...$1,710K Accrued royalties$1,116K (0.00%↑ Y/Y)Accrued expenses andother current...$1,000K (75.13%↑ Y/Y)Contingent considerationliabilities, current$706K (2.47%↑ Y/Y)

Insight Molecular Diagnostics Inc. (IMDX)

Insight Molecular Diagnostics Inc. (IMDX)